Novartis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
CEOVasant Narasimhan
CEOVasant Narasimhan
Employees75,883
Employees75,883
HeadquartersBasel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded1996
Founded1996
Employees75,883
Employees75,883
NVS Key Statistics
Market cap256.73B
Market cap256.73B
Price-Earnings ratio18.95
Price-Earnings ratio18.95
Dividend yield2.69%
Dividend yield2.69%
Average volume1.40M
Average volume1.40M
High today$122.81
High today$122.81
Low today$121.12
Low today$121.12
Open price$122.32
Open price$122.32
Volume910.38K
Volume910.38K
52 Week high$124.45
52 Week high$124.45
52 Week low$96.06
52 Week low$96.06
NVS News
TipRanks 2d
Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment?Novartis AG ((NVS)), DEL_Novartis (0QM7) ((DEL_0QM7)), DEL_Novartis Inc ((DEL_0QLR)), Novartis ((CH:NOVN)) announced an update on their ongoing clinical study....
Benzinga 3d
Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis TrialNovartis AG NVS on Thursday released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing giant ce...
Analyst ratings
56%
of 25 ratingsBuy
20%
Hold
56%
Sell
24%